Extension of the survival dimensionality reduction algorithm to detect epistasis in competing risks models (SDR-CR)

[1]  Torsten Witte,et al.  Identification of CSK as a systemic sclerosis genetic risk factor through Genome Wide Association Study follow-up. , 2012, Human molecular genetics.

[2]  Giota Touloumi,et al.  Practical methods for competing risks data: A review , 2012, Statistical methods in medical research.

[3]  P. Sham,et al.  Evaluating the heritability explained by known susceptibility variants: a survey of ten complex diseases , 2011, Genetic epidemiology.

[4]  Stefan Behnel,et al.  Cython: The Best of Both Worlds , 2011, Computing in Science & Engineering.

[5]  Richard M. Simon,et al.  Using cross-validation to evaluate predictive accuracy of survival risk classifiers based on high-dimensional data , 2011, Briefings Bioinform..

[6]  Harald Binder,et al.  Quantifying the predictive accuracy of time‐to‐event models in the presence of competing risks , 2011, Biometrical journal. Biometrische Zeitschrift.

[7]  Lorenzo Beretta,et al.  Survival dimensionality reduction (SDR): development and clinical application of an innovative approach to detect epistasis in presence of right-censored data , 2010, BMC Bioinformatics.

[8]  Jason H. Moore,et al.  Missing heritability and strategies for finding the underlying causes of complex disease , 2010, Nature Reviews Genetics.

[9]  David N Cooper,et al.  GWAS: heritability missing in action? , 2010, European Journal of Human Genetics.

[10]  Judy H. Cho,et al.  Finding the missing heritability of complex diseases , 2009, Nature.

[11]  H. Cordell.  Detecting gene–gene interactions that underlie human diseases , 2009, Nature Reviews Genetics.

[12]  Martin Schumacher,et al.  Simulating competing risks data in survival analysis , 2009, Statistics in medicine.

[13]  M. L. Calle,et al.  Improving strategies for detecting genetic patterns of disease susceptibility in association studies , 2008, Statistics in medicine.

[14]  M. Ritchie,et al.  Exploring the Performance of Multifactor Dimensionality Reduction in Large Scale SNP Studies and in the Presence of Genetic Heterogeneity among Epistatic Disease Models , 2008, Human Heredity.

[15]  Casey S Greene,et al.  Ability of epistatic interactions of cytokine single-nucleotide polymorphisms to predict susceptibility to disease subsets in systemic sclerosis patients. , 2008, Arthritis and rheumatism.

[16]  D. Hansell,et al.  Interstitial lung disease in systemic sclerosis: a simple staging system. , 2008, American journal of respiratory and critical care medicine.

[17]  Yingjie Lan,et al.  The logistic–exponential survival distribution , 2008 .

[18]  H Putter,et al.  Tutorial in biostatistics: competing risks and multi‐state models , 2007, Statistics in medicine.

[19]  Haesook T. Kim.  Cumulative Incidence in Competing Risks Data and Competing Risks Regression Analysis , 2007, Clinical Cancer Research.

[20]  A. Wells,et al.  Pulmonary complications: one of the most challenging complications of systemic sclerosis. , 2006, Rheumatology.

[21]  Jason H. Moore,et al.  Dissecting trait heterogeneity: a comparison of three clustering methods applied to genotypic data , 2006, BMC Bioinformatics.

[22]  Scott M. Williams,et al.  Traversing the conceptual divide between biological and statistical epistasis: systems biology and a more modern synthesis. , 2005, BioEssays : news and reviews in molecular, cellular and developmental biology.

[23]  E. Hofny,et al.  Alterations of mononuclear inflammatory cells, CD4/CD8+ T cells, interleukin 1β, and tumour necrosis factor α in the bronchoalveolar lavage fluid, peripheral blood, and skin of patients with systemic sclerosis , 2005, Journal of Clinical Pathology.

[24]  Jason H. Moore,et al.  The Ubiquitous Nature of Epistasis in Determining Susceptibility to Common Human Diseases , 2003, Human Heredity.

[25]  T. Reich,et al.  A perspective on epistasis: limits of models displaying no main effect. , 2002, American journal of human genetics.

[26]  E Graf,et al.  Assessment and comparison of prognostic classification schemes for survival data. , 1999, Statistics in medicine.

[27]  Robert Gray,et al.  A Proportional Hazards Model for the Subdistribution of a Competing Risk , 1999 .

[28]  J Crowley,et al.  Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. , 1999, Statistics in medicine.

[29]  Kristel Van Steen,et al.  Travelling the world of gene-gene interactions , 2012, Briefings Bioinform..

[30]  Angeline S. Andrew,et al.  A novel survival multifactor dimensionality reduction method for detecting gene–gene interactions with application to bladder cancer prognosis , 2010, Human Genetics.

[31]  David M. Reif,et al.  Machine Learning for Detecting Gene-Gene Interactions , 2006, Applied bioinformatics.